Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Platelet-derived Growth factor-BB (PDGF-BB)
88%
Vascular Smooth muscle Cells
82%
Vascular Smooth muscle Cell Proliferation
77%
Insulin
69%
AMP-activated Protein Kinase
66%
Nitric Oxide
56%
Human Aortic Smooth muscle Cells (HASMCs)
53%
Insulin Receptor Signaling
43%
Cyclic GMP
42%
Intimal Hyperplasia
42%
Phosphorylation
42%
Diabetes
42%
Rat Cardiomyocytes
40%
Sulforaphane
40%
Ca2+
36%
Leptin
35%
Protein Kinase B
30%
Insulin Receptor Substrate 1 (IRS1)
29%
Neointima Formation
29%
Mammalian Target of Rapamycin (mTOR)
29%
Rat Retina
28%
Protein Kinase C
28%
Type 2 Diabetes Mellitus (T2DM)
28%
Kinase-independent
28%
Imatinib
28%
Growth Arrest
27%
AKT1
27%
Retina
26%
Negative Inotropic Effect
26%
Ceramide
26%
Ins2
26%
Retinal Ganglion cell-5
26%
Obese Mice
26%
Metformin
26%
Akita
26%
Hypercholesterolemia
26%
Pioglitazone
26%
Retinal Ganglion Cells
26%
Contractile Response
25%
Diabetic
25%
Platelet-derived Growth Factor Receptor (PDGFR)
24%
Phosphoinositide 3-kinase (PI3K)
24%
Kinase Activity
23%
Attenuation
23%
ApoE KO Mice
23%
P70S6K
22%
S-nitroso-N-acetylpenicillamine
20%
Endothelium
20%
Insulin Resistance
20%
Proliferative Signaling
19%
Pharmacology, Toxicology and Pharmaceutical Science
Platelet Derived Growth Factor
100%
Protein Kinase B
95%
Rat
86%
Insulin
56%
Nitric Oxide
53%
Phosphatidylinositol 3 Kinase
44%
Cyclic GMP
43%
Protein Kinase C
33%
Growth Disorder
28%
Insulin Receptor
28%
Imatinib
28%
Hyperplasia
27%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
26%
Calcium Ion
26%
Leptin
26%
Mouse Mutant
26%
Sulforaphane
26%
Platelet Derived Growth Factor Receptor
26%
Insulin Resistance
22%
S-Nitroso-N-Acetylpenicillamine
20%
Glucose
20%
Maturity Onset Diabetes of the Young
18%
Insulin Receptor Substrate 1
17%
Pertussis Toxin
17%
Neointima
17%
Isoprenaline
17%
Artery Injury
16%
Protein Kinase C Inhibitor
16%
Mitogen Activated Protein Kinase
16%
Insulin Receptor Substrate
16%
Guanine Nucleotide Binding Protein
15%
Angiotensin II
15%
Insulin Receptor Substrate 2
14%
Nitric Oxide Donor
14%
Pioglitazone
13%
Adenosine Diphosphate
13%
Metformin
13%
Metabolic Acidosis
13%
Receptor Agonist
13%
Carbachol
13%
Experimental Diabetes Mellitus
13%
Vasopressin
13%
PPAR Agonist
13%
Dipeptidyl Peptidase
13%
Peptide
13%
Ceramide
13%
sodium glucose cotransporter-2 inhibitors
13%
Endotoxin
13%
Sucrose
13%
Dipeptidyl Peptidase IV Inhibitor
13%
Medicine and Dentistry
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
40%
phosphorylation
39%
Insulin
36%
Endothelium
31%
Diabetes
27%
Neointimal Hyperplasia
27%
Smooth Muscle
26%
Insulin Receptor
26%
Glucose
22%
Vascular Smooth Muscle Cell
20%
Vasodilatation
20%
Nitric Oxide
16%
Insulin Resistance
16%
Diabetic Retinopathy
16%
Adenosine Diphosphate
15%
Phenylephrine
15%
Protein Phosphorylation
14%
Adenosine Triphosphate
14%
Adenosine Diphosphate Ribosylation
13%
Femoral Artery
13%
Inotropy
13%
Leptin
13%
Contractile Function
13%
Hypoxia
13%
High Fat/High Sucrose Diet
13%
Neointima
13%
Microangiopathy
13%
Cyclic GMP
13%
Ceramide
13%
Myocardium
13%
Glycon
13%
Platelet Derived Growth Factor
13%
5 Amino 4 Imidazolecarboxamide Riboside
13%
Saphenous Vein
13%
Fructose
13%
Sulforaphane
13%
AMP-Activated Protein Kinase
13%
Glucose Uptake
13%
Pioglitazone
13%
Cardiac Muscle Cell
13%
Retinopathy
13%
Endotoxin
13%
High Fat Food
13%
Carotid Artery
13%
Serotonin
13%
Imatinib
13%
Protein Kinase B
10%
Vascular Smooth Muscle
9%
G Protein Coupled Receptor
8%